BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21192162)

  • 1. Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.
    Caykoylu A; Ekinci O; Ugurlu GK; Albayrak Y
    J Clin Psychopharmacol; 2011 Feb; 31(1):134-5. PubMed ID: 21192162
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder.
    Chen MH; Liou YJ
    J Clin Psychopharmacol; 2013 Apr; 33(2):269-70. PubMed ID: 23422384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
    De Schutter P; Bouckaert F; Peuskens J
    Tijdschr Psychiatr; 2011; 53(5):299-303. PubMed ID: 21538299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.
    Kemp DE; Gilmer WS; Fleck J; Straus JL; Dago PL; Karaffa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):574-7. PubMed ID: 17234318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin.
    De Berardis D; Serroni N; Moschetta FS; Martinotti G; Di Giannantonio M
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E9-10. PubMed ID: 23686043
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
    Thase ME; Bowden CL; Nashat M; Eudicone JM; Marcus R; McQuade RD; Carlson BX
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):121-31. PubMed ID: 22296512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable aripiprazole-induced tardive writer's cramp.
    Sato K; Yoshida K; Higuchi H
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E44. PubMed ID: 23037681
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
    Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
    J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.
    Saddichha S; Kumar R; Babu GN; Chandra P
    J Clin Pharmacol; 2012 Sep; 52(9):1448-9. PubMed ID: 21903892
    [No Abstract]   [Full Text] [Related]  

  • 11. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 12. Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder.
    Shepherd J; Garza VM; De León OA
    J Clin Psychopharmacol; 2009 Oct; 29(5):503-4. PubMed ID: 19745656
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Psychiatry Res; 2009 Jan; 165(1-2):193-6. PubMed ID: 18973955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three cases of hypomania and one case of mania during aripiprazole treatment.
    Viikki M; Valtonen HM; Leinonen E
    Pharmacopsychiatry; 2011 Mar; 44(2):78-81. PubMed ID: 21157696
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
    Uguz F
    Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible dopamine transporter reduction in drug-induced Parkinsonism.
    Cilia R; Marotta G; Belletti A; Siri C; Pezzoli G
    Mov Disord; 2014 Apr; 29(4):575-7. PubMed ID: 24532036
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.